Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients.
Front Endocrinol (Lausanne)
; 14: 1236404, 2023.
Article
in En
| MEDLINE
| ID: mdl-38047108
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
/
Diabetes Mellitus, Type 2
/
Renal Insufficiency, Chronic
/
Sodium-Glucose Transporter 2 Inhibitors
/
Heart Failure
Type of study:
Systematic_reviews
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Front Endocrinol (Lausanne)
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland